Insider
Date
Role
Action
Shares
Price
Amount
Cyrus Harmon
24 Jul 2026
Director
Sell
12,500
$11.71
$146.43K
Cyrus Harmon
23 Jul 2026
Director
Sell
12,500
$11.58
$144.74K
Shawnte Mitchell
4 Mar 2026
Chief Legal Officer
Sold after exercise
233
$24.69
$5.75K
Shawnte Mitchell
4 Mar 2026
Chief Legal Officer
Sold after exercise
24,767
$24.25
$600.60K
Shawnte Mitchell
3 Mar 2026
Chief Legal Officer
Sold after exercise
15,000
$23.01
$345.15K
Cyrus Harmon
20 Jan 2026
Director
Sell
10,000
$26.88
$268.80K
Shane William Charles Kovacs
15 Jan 2026
Ch. Operating & Financial Off.
Sell
100,000
$28.73
$2.87M
David C. Myles
14 Jan 2026
Ch. Discov. & Non-Clin Dev Off
Sold after exercise
35,003
$28.99
$1.01M
David C. Myles
14 Jan 2026
Ch. Discov. & Non-Clin Dev Off
Sold after exercise
14,997
$28.60
$428.91K
Cyrus Harmon
14 Jan 2026
Director
Sell
3,489
$29.12
$101.60K
David C. Myles
13 Jan 2026
Ch. Discov. & Non-Clin Dev Off
Sold after exercise
200
$28.49
$5.70K
David C. Myles
13 Jan 2026
Ch. Discov. & Non-Clin Dev Off
Sold after exercise
49,800
$27.60
$1.37M
Shane William Charles Kovacs
13 Jan 2026
Ch. Operating & Financial Off.
Sell
3,822
$28.01
$107.05K
David C. Myles
12 Jan 2026
Ch. Discov. & Non-Clin Dev Off
Sell
indirect
10,000
$28.34
$283.40K
Naseem Zojwalla
23 Dec 2025
Chief Medical Officer
Sold after exercise
99,509
$27.66
$2.75M
Naseem Zojwalla
22 Dec 2025
Chief Medical Officer
Sold after exercise
100,000
$28.04
$2.80M
Cyrus Harmon
22 Dec 2025
Director
Sell
2,881
$28.53
$82.19K
Naseem Zojwalla
19 Dec 2025
Chief Medical Officer
Sold after exercise
12,921
$28.93
$373.80K
Naseem Zojwalla
19 Dec 2025
Chief Medical Officer
Sold after exercise
57,079
$28.03
$1.60M
David C. Myles
19 Dec 2025
Ch. Discov. & Non-Clin Dev Off
Sell
6,046
$31.39
$189.78K
David C. Myles
19 Dec 2025
Ch. Discov. & Non-Clin Dev Off
Sell
43,729
$30.40
$1.33M
David C. Myles
19 Dec 2025
Ch. Discov. & Non-Clin Dev Off
Sell
1,225
$28.08
$34.40K
Ian T Clark
19 Dec 2025
Director
Sold after exercise
41,840
$30.48
$1.28M
Ian T Clark
19 Dec 2025
Director
Sold after exercise
193,056
$29.71
$5.74M
Ian T Clark
19 Dec 2025
Director
Sold after exercise
29,904
$28.83
$862.13K
Andrew Rappaport
21 Nov 2025
Director
Exercised, kept
35,868
$0.39
$13.99K
Cyrus Harmon
18 Sep 2025
Director
Sell
indirect
3,086
$8.32
$25.68K
Cyrus Harmon
18 Sep 2025
Director
Sell
10,000
$8.33
$83.30K
Cyrus Harmon
16 Sep 2025
Director
Sell
indirect
1,914
$8.08
$15.47K
Cyrus Harmon
16 Sep 2025
Director
Sell
10,000
$8.04
$80.40K
Bain Capital Life Sciences Investors, LLC
8 Jan 2025
10% owner
Buy
indirect
300,000
$5.76
$1.73M
G. Walmsley Graham
17 Dec 2024
Director
Buy
indirect
700,761
$6.75
$4.73M
G. Walmsley Graham
17 Dec 2024
Director
Sell
indirect
700,761
$6.75
$4.73M
Naseem Zojwalla
16 Dec 2024
Chief Medical Officer
Exercised, kept
14,000
$4.87
$68.18K
Sean Bohen
11 Dec 2024
President and CEO
Sell
1,267
$9.39
$11.90K
Sean Bohen
11 Dec 2024
President and CEO
Sell
55,907
$8.66
$484.15K
Shane William Charles Kovacs
11 Dec 2024
Ch. Operating & Financial Off.
Sell
406
$9.39
$3.81K
Shane William Charles Kovacs
11 Dec 2024
Ch. Operating & Financial Off.
Sell
17,950
$8.66
$155.45K
Naseem Zojwalla
11 Dec 2024
Chief Medical Officer
Sell
320
$9.39
$3.00K
Naseem Zojwalla
11 Dec 2024
Chief Medical Officer
Sell
14,202
$8.66
$122.99K
David C. Myles
11 Dec 2024
Ch. Discov. & Non-Clin Dev Off
Sell
300
$9.39
$2.82K
David C. Myles
11 Dec 2024
Ch. Discov. & Non-Clin Dev Off
Sell
13,314
$8.66
$115.30K
Cyrus Harmon
11 Dec 2024
Director
Sell
179
$9.39
$1.68K
Cyrus Harmon
11 Dec 2024
Director
Sell
7,958
$8.66
$68.92K
Sean Bohen
10 Dec 2024
President and CEO
Sell
52,328
$9.37
$490.31K
Shane William Charles Kovacs
10 Dec 2024
Ch. Operating & Financial Off.
Sell
16,803
$9.37
$157.44K
Naseem Zojwalla
10 Dec 2024
Chief Medical Officer
Sell
13,283
$9.37
$124.46K
David C. Myles
10 Dec 2024
Ch. Discov. & Non-Clin Dev Off
Sell
12,452
$9.38
$116.80K
Cyrus Harmon
10 Dec 2024
Director
Sell
8,256
$9.37
$77.36K
Shane William Charles Kovacs
15 Nov 2024
Ch. Operating & Financial Off.
Exercised, kept
25,000
$7.02
$175.50K
Paradigm Biocapital Advisors LP
1 Aug 2024
10% owner
Sell
indirect
529,501
$14.92
$7.90M
Paradigm Biocapital Advisors LP
1 Aug 2024
10% owner
Sell
indirect
1,870,499
$14.92
$27.90M
Cyrus Harmon
30 Jul 2024
Director
Sold on a plan
934
$15.55
$14.52K
Cyrus Harmon
29 Jul 2024
Director
Sold on a plan
4,066
$15.58
$63.35K
Cyrus Harmon
11 Jul 2024
Director
Sold on a plan
5,000
$12.26
$61.30K
Cyrus Harmon
28 Jun 2024
Director
Sold on a plan
20,000
$10.77
$215.40K
Cyrus Harmon
4 Jun 2024
Director
Sold on a plan
5,000
$12.33
$61.65K
G. Walmsley Graham
4 Jun 2024
Director
Sell
indirect
475,000
$14.85
$7.05M
G. Walmsley Graham
4 Jun 2024
Director
Sell
indirect
700,000
$14.85
$10.40M
Cyrus Harmon
3 Jun 2024
Director
Sold on a plan
5,000
$10.93
$54.65K
Cyrus Harmon
31 May 2024
Director
Sold on a plan
15,000
$9.41
$141.15K
Naseem Zojwalla
24 May 2024
Chief Medical Officer
Exercised, kept
9,460
$4.87
$46.07K
Cyrus Harmon
6 May 2024
Director
Sold on a plan
5,000
$10.92
$54.60K
Cyrus Harmon
30 Apr 2024
Director
Sold on a plan
15,000
$9.51
$142.65K
Cyrus Harmon
28 Mar 2024
Director
Sold on a plan
20,000
$10.97
$219.40K
Naseem Zojwalla
18 Mar 2024
Chief Medical Officer
Exercised, kept
13,700
$4.87
$66.72K
Cyrus Harmon
29 Feb 2024
Director
Sold on a plan
100
$13.00
$1.30K
Cyrus Harmon
29 Feb 2024
Director
Sold on a plan
24,900
$12.41
$309.01K
Cyrus Harmon
1 Feb 2024
Director
Sold on a plan
5,000
$15.56
$77.80K
Cyrus Harmon
31 Jan 2024
Director
Sold on a plan
25,000
$12.23
$305.75K
Naseem Zojwalla
25 Jan 2024
Chief Medical Officer
Exercised, kept
20,000
$7.02
$140.40K
Shane William Charles Kovacs
12 Jan 2024
Ch. Operating & Financial Off.
Exercised, kept
50,000
$7.02
$351.00K
Cyrus Harmon
29 Dec 2023
Director
Sell
2,500
$14.10
$35.25K
Cyrus Harmon
29 Dec 2023
Director
Sell
22,500
$13.30
$299.25K
Shane William Charles Kovacs
12 Dec 2023
Ch. Operating & Financial Off.
Exercised, kept
10,000
$7.02
$70.20K
Naseem Zojwalla
11 Dec 2023
Chief Medical Officer
Exercised, kept
2,900
$7.02
$20.36K
Naseem Zojwalla
6 Dec 2023
Chief Medical Officer
Exercised, kept
13,100
$7.02
$91.96K
Paradigm Biocapital Advisors LP
6 Dec 2023
10% owner
Buy
indirect
100,000
$11.60
$1.16M
G. Walmsley Graham
5 Dec 2023
Director
Buy
indirect
50,000
$13.09
$654.25K
G. Walmsley Graham
5 Dec 2023
Director
Buy
indirect
50,000
$14.95
$747.48K
G. Walmsley Graham
5 Dec 2023
Director
Buy
indirect
31,870
$14.73
$469.55K
Cyrus Harmon
30 Nov 2023
Director
Sold on a plan
25,000
$12.57
$314.25K
Shane William Charles Kovacs
22 Nov 2023
Ch. Operating & Financial Off.
Sell
9,145
$13.89
$127.02K
Sean Bohen
22 Nov 2023
President and CEO
Sell
27,932
$13.90
$388.25K
David C. Myles
22 Nov 2023
Ch. Discov. & Non-Clin Dev Off
Sell
6,653
$13.89
$92.41K
Naseem Zojwalla
22 Nov 2023
Chief Medical Officer
Sell
7,095
$13.89
$98.55K
Cyrus Harmon
22 Nov 2023
Director
Sell
3,989
$13.90
$55.45K
Shane William Charles Kovacs
21 Nov 2023
Ch. Operating & Financial Off.
Sell
700
$15.27
$10.69K
Shane William Charles Kovacs
21 Nov 2023
Ch. Operating & Financial Off.
Sell
8,897
$14.83
$131.94K
Sean Bohen
21 Nov 2023
President and CEO
Sell
2,602
$15.29
$39.78K
Sean Bohen
21 Nov 2023
President and CEO
Sell
26,691
$14.84
$396.09K
David C. Myles
21 Nov 2023
Ch. Discov. & Non-Clin Dev Off
Sell
200
$15.32
$3.06K
David C. Myles
21 Nov 2023
Ch. Discov. & Non-Clin Dev Off
Sell
6,776
$14.87
$100.76K
Naseem Zojwalla
21 Nov 2023
Chief Medical Officer
Sell
200
$15.33
$3.07K
Naseem Zojwalla
21 Nov 2023
Chief Medical Officer
Sell
7,261
$14.83
$107.68K
Cyrus Harmon
21 Nov 2023
Director
Sell
4,192
$14.86
$62.29K
David C. Myles
8 Nov 2023
Ch. Discov. & Non-Clin Dev Off
Sold on a plan
200
$17.61
$3.52K
David C. Myles
3 Nov 2023
Ch. Discov. & Non-Clin Dev Off
Sold on a plan
541
$17.51
$9.47K
Cyrus Harmon
2 Nov 2023
Director
Sold on a plan
5,000
$15.64
$78.20K
David C. Myles
2 Nov 2023
Ch. Discov. & Non-Clin Dev Off
Sold on a plan
3,332
$15.36
$51.18K
David C. Myles
1 Nov 2023
Ch. Discov. & Non-Clin Dev Off
Sold on a plan
6,668
$15.02
$100.15K
Cyrus Harmon
31 Oct 2023
Director
Sold on a plan
25,000
$12.05
$301.25K
Cyrus Harmon
29 Sep 2023
Director
Sold on a plan
25,000
$12.41
$310.25K
David C. Myles
19 Sep 2023
Ch. Discov. & Non-Clin Dev Off
Sold on a plan
20,000
$12.67
$253.40K
Bvf Partners L P/Il
12 Sep 2023
Director
Buy
52,801
$9.84
$519.56K
Bvf Partners L P/Il
12 Sep 2023
Director
Buy
677,853
$9.84
$6.67M
Bvf Partners L P/Il
12 Sep 2023
Director
Buy
775,278
$9.84
$7.63M
G. Walmsley Graham
12 Sep 2023
Director
Buy
indirect
508,130
$9.84
$5.00M
Cyrus Harmon
5 Sep 2023
Director
Sold on a plan
10,000
$11.62
$116.20K
Cyrus Harmon
31 Aug 2023
Director
Sold on a plan
15,000
$9.36
$140.40K
Cyrus Harmon
16 Aug 2023
Director
Sold on a plan
15,000
$10.14
$152.10K
Cyrus Harmon
8 Jun 2023
Director
Sell
10,000
$6.30
$63.00K
Cyrus Harmon
6 Jun 2023
Director
Sell
5,000
$6.30
$31.48K
Cyrus Harmon
5 Jun 2023
Director
Sell
5,000
$6.05
$30.23K
Shane William Charles Kovacs
6 Apr 2023
Ch. Operating & Financial Off.
Buy
10,000
—
no price
Shane William Charles Kovacs
2 Sep 2022
Ch. Operating & Financial Off.
Buy
20,000
—
no price
Bvf Partners L P/Il
10 Jun 2022
Director
Buy
41,417
$4.03
$167.10K
Bvf Partners L P/Il
10 Jun 2022
Director
Buy
158,583
$4.03
$639.80K
Kinney Horn
10 Mar 2022
Chief Business Officer
Sold after exercise
5,253
$4.75
$24.95K
Kinney Horn
10 Feb 2022
Chief Business Officer
Exercised, kept
5,251
$2.06
$10.84K
Kinney Horn
10 Jan 2022
Chief Business Officer
Sold after exercise
5,251
$6.85
$35.97K
David C. Myles
10 Dec 2021
Chief Development Officer
Sell
10,000
$10.30
$103.00K
Kinney Horn
10 Dec 2021
Chief Business Officer
Sold after exercise
5,251
$10.39
$54.56K
Bvf Partners L P/Il
30 Nov 2021
Director
Buy
35,268
$9.39
$331.18K
Bvf Partners L P/Il
30 Nov 2021
Director
Buy
341,977
$9.39
$3.21M
Bvf Partners L P/Il
30 Nov 2021
Director
Buy
362,430
$9.39
$3.40M
Cyrus Harmon
29 Nov 2021
Chief Technology Officer
Sell
400
$24.76
$9.90K
Kinney Horn
10 Nov 2021
Chief Business Officer
Sold after exercise
27,668
$26.88
$743.72K
Cyrus Harmon
19 Oct 2021
Chief Technology Officer
Sell
4,555
$28.20
$128.45K
Cyrus Harmon
19 Oct 2021
Chief Technology Officer
Sell
7,445
$27.85
$207.34K
Sean Bohen
14 Oct 2021
President and CEO
Sold after exercise
351
$31.17
$10.94K
Sean Bohen
14 Oct 2021
President and CEO
Sold after exercise
4,649
$30.42
$141.42K
Kinney Horn
11 Oct 2021
Chief Business Officer
Sold after exercise
3,146
$28.19
$88.69K
Kinney Horn
11 Oct 2021
Chief Business Officer
Sold after exercise
2,105
$27.47
$57.82K
Sean Bohen
27 Sep 2021
President and CEO
Sold after exercise
1,085
$30.07
$32.63K
Cyrus Harmon
20 Sep 2021
Chief Technology Officer
Sell
12,000
$26.30
$315.60K
Kinney Horn
10 Sep 2021
Chief Business Officer
Sold after exercise
5,251
$29.38
$154.27K
Sean Bohen
8 Sep 2021
President and CEO
Sold after exercise
2,631
$30.00
$78.93K
Sean Bohen
7 Sep 2021
President and CEO
Sold after exercise
413
$30.08
$12.42K
Sean Bohen
1 Sep 2021
President and CEO
Sold after exercise
871
$30.05
$26.17K
Cyrus Harmon
19 Aug 2021
Chief Technology Officer
Sell
12,000
$24.97
$299.64K
Kinney Horn
10 Aug 2021
Chief Business Officer
Sold after exercise
60
$26.17
$1.57K
Kinney Horn
10 Aug 2021
Chief Business Officer
Sold after exercise
5,191
$25.70
$133.41K
Cyrus Harmon
20 Jul 2021
Chief Technology Officer
Sell
4,123
$25.63
$105.67K
Cyrus Harmon
19 Jul 2021
Chief Technology Officer
Sell
7,877
$24.83
$195.59K
Kinney Horn
12 Jul 2021
Chief Business Officer
Sold after exercise
1,392
$27.00
$37.58K
Kinney Horn
12 Jul 2021
Chief Business Officer
Sold after exercise
3,859
$26.33
$101.61K
Cyrus Harmon
18 Jun 2021
Chief Technology Officer
Sell
600
$26.30
$15.78K
Cyrus Harmon
18 Jun 2021
Chief Technology Officer
Sell
1,990
$25.59
$50.92K
Cyrus Harmon
18 Jun 2021
Chief Technology Officer
Sell
9,410
$24.54
$230.92K
Kinney Horn
10 Jun 2021
Chief Business Officer
Sold after exercise
2,787
$29.97
$83.53K
Kinney Horn
10 Jun 2021
Chief Business Officer
Sold after exercise
2,164
$29.60
$64.05K
Kinney Horn
10 Jun 2021
Chief Business Officer
Sold after exercise
300
$28.30
$8.49K
Kinney Horn
18 May 2021
Chief Business Officer
Sold after exercise
8,621
$24.81
$213.89K
Kinney Horn
18 May 2021
Chief Business Officer
Sold after exercise
49,142
$24.03
$1.18M
G. Walmsley Graham
23 Nov 2020
Director
Buy
indirect
1,160,000
$19.00
$22.04M
Cormorant Asset Management, LP
23 Nov 2020
Former 10% Owner
Buy
indirect
425,000
$19.00
$8.08M
Bvf Partners L P/Il
19 Nov 2020
Director
Buy
74,991
$19.00
$1.42M
Bvf Partners L P/Il
19 Nov 2020
Director
Buy
446,425
$19.00
$8.48M
Bvf Partners L P/Il
19 Nov 2020
Director
Buy
613,918
$19.00
$11.66M
Sean Bohen
23 Sep 2020
President and CEO
Exercised, kept
51,649
$4.82
$249.15K
Cynthia M Butitta
16 Sep 2020
Director
Exercised, kept
83,876
$4.41
$369.56K
